Skip to main content

Transplant Tourism and the Traveling Transplant Recipient: Infection Mitigation and Treatment Strategies

  • Reference work entry
  • First Online:
Emerging Transplant Infections
  • 1175 Accesses

Abstract

Transplant tourism and travel posttransplant, both solid organ and hematopoietic stem cell, are important and distinct topics, and each poses a risk of infection for transplant recipients. As solid organ transplant becomes a more common treatment option for end-stage organ disease, wait lists and wait times for these organs grow. Transplant tourism involves traveling abroad for the purposes of organ transplant and often involves commercial transactions. This process has been discouraged on ethical grounds and is illegal in many countries, however it still occurs. Patients may also travel abroad for stem cell therapies, which include experimental treatments for a growing number of diseases. Physicians managing patients who have received transplants abroad should be aware of the risk of infection in these patients which will be outlined in this chapter. Separate to this, the second part of this chapter addresses the topic of travel in post transplant patients. Solid organ and hematopoietic stem cell transplant recipients may wish to travel as part of their return to regular activities and lifestyle posttransplant. All transplant recipients should seek medical advice prior to travel abroad, and risk of infection will depend on destination(s) and type of travel. Risk reduction strategies are important for these patients to allow for safe travel posttransplant and will be discussed in detail in this chapter.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Kotton CN, Hibberd PL. Travel medicine and transplant tourism in solid organ transplantation. Am J Transplant. 2013;13(s4):337–47. https://doi.org/10.1111/ajt.12125.

    Article  CAS  PubMed  Google Scholar 

  2. Human Organ and Tissue Transplantation. 2004. https://www.who.int/transplantation/en/A57_R18-en.pdf. Accessed 25 Feb 2019.

  3. Participants in the International Summit on Transplant Tourism and Organ Trafficking Convened by the Transplantation Society and International Society of Nephrology in Istanbul, Turkey, April 30–May 2, 2008. The declaration of Istanbul on organ trafficking and transplant tourism. Transplantation. 2008;86(8):1013–8. https://doi.org/10.1097/TP.0b013e318185ffc9.

    Article  Google Scholar 

  4. The Declaration of Istanbul on Organ Trafficking and Transplant Tourism (2018 Edition). 2018. https://www.declarationofistanbul.org/images/Policy_Documents/2018_Ed_Do/2018_Edition_of_the_Declaration_of_Istanbul_Final.pdf. Accessed 30 July 2018.

  5. Caulfield T, Zarzeczny A. Curbing transplant tourism: Canadian physicians and the law. CMAJ. 2016;188(13):935–6. https://doi.org/10.1503/cmaj.160497.

    Article  PubMed  PubMed Central  Google Scholar 

  6. WHO | WHO proposes global agenda on transplantation. WHO. 2010. http://www.who.int/mediacentre/news/releases/2007/pr12/en/. Accessed 1 Aug 2018.

  7. Prasad GVR, Shukla A, Huang M, D’A Honey RJ, Zaltzman JS. Outcomes of commercial renal transplantation: a Canadian experience. Transplantation. 2006;82(9):1130–5. https://doi.org/10.1097/01.tp.0000241072.03400.11.

    Article  PubMed  Google Scholar 

  8. Prasad GVR, Ananth S, Palepu S, Huang M, Nash MM, Zaltzman JS. Commercial kidney transplantation is an important risk factor in long-term kidney allograft survival. Kidney Int. 2016;89(5):1119–24. https://doi.org/10.1016/j.kint.2015.12.047.

    Article  PubMed  Google Scholar 

  9. Geddes CC, Henderson A, Mackenzie P, Rodger SC. Outcome of patients from the west of Scotland traveling to Pakistan for living donor kidney transplants. Transplantation. 2008;86(8):1143–5. https://doi.org/10.1097/TP.0b013e318187cdd0.

    Article  PubMed  Google Scholar 

  10. Gill J, Madhira BR, Gjertson D, et al. Transplant tourism in the United States: a single-center experience. Clin J Am Soc Nephrol. 2008;3(6):1820–8. https://doi.org/10.2215/CJN.02180508.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Cha R-H, Kim YC, Oh YJ, et al. Long-term outcomes of kidney allografts obtained by transplant tourism: observations from a single center in Korea. Nephrology. 2011;16(7):672–9. https://doi.org/10.1111/j.1440-1797.2011.01480.x.

    Article  PubMed  Google Scholar 

  12. Babik JM, Chin-Hong P. Transplant tourism: understanding the risks. Curr Infect Dis Rep. 2015;17(4):18. https://doi.org/10.1007/s11908-015-0473-x.

    Article  Google Scholar 

  13. Quach K, Sultan H, Li Y, Famure O, Kim SJ. Outcomes of kidney transplantation abroad. Prog Transplant. 2016;26(1):5–12. https://doi.org/10.1177/1526924816632133.

    Article  PubMed  Google Scholar 

  14. American Society for Transplantation and Cellular Therapy. Stem cell therapy and medical tourism – American Society for Transplantation and Cellular Therapy. https://www.asbmt.org/practice-resources/policy-statements/stem-cell-therapy-and-medical-tourism. Accessed 7 Oct 2019.

  15. Buchan CA, Kotton CN. Travel medicine, transplant tourism, and the solid organ transplant recipient – guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33(9):e13529. https://doi.org/10.1111/ctr.13529.

    Article  Google Scholar 

  16. Kennedy SE, Shen Y, Charlesworth JA, et al. Outcome of overseas commercial kidney transplantation: an Australian perspective. Med J Aust. 2005;182(5):224–7. http://www.ncbi.nlm.nih.gov/pubmed/15748132. Accessed 30 July 2018

    Article  Google Scholar 

  17. Sever MŞ, Kazancioğlu R, Yildiz A, et al. Outcome of living unrelated (commercial) renal transplantation. Kidney Int. 2001;60(4):1477–83. https://doi.org/10.1046/j.1523-1755.2001.00951.x.

    Article  CAS  PubMed  Google Scholar 

  18. Chen LH, Wilson ME. The globalization of healthcare: implications of medical tourism for the infectious disease clinician. Clin Infect Dis. 2013;57(12):1752–9. https://doi.org/10.1093/cid/cit540.

    Article  PubMed  Google Scholar 

  19. Merion RM, Barnes AD, Lin M, et al. Transplants in foreign countries among patients removed from the US transplant waiting list. Am J Transplant. 2008;8(4p2):988–96. https://doi.org/10.1111/j.1600-6143.2008.02176.x.

    Article  CAS  PubMed  Google Scholar 

  20. Gill J, Diec O, Landsberg DN, et al. Opportunities to deter transplant tourism exist before referral for transplantation and during the workup and management of transplant candidates. Kidney Int. 2011;79(9):1026–31. https://doi.org/10.1038/ki.2010.540.

    Article  PubMed  Google Scholar 

  21. Martín-Dávila P, Fortún J, López-Vélez R, et al. Transmission of tropical and geographically restricted infections during solid-organ transplantation. Clin Microbiol Rev. 2008;21(1):60–96. https://doi.org/10.1128/CMR.00021-07.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Marks PW, Witten CM, Califf RM. Clarifying stem-cell therapy’s benefits and risks. N Engl J Med. 2017;376(11):1007–9. https://doi.org/10.1056/NEJMp1613723.

    Article  PubMed  Google Scholar 

  23. Caulfield T, Zarzeczny A, Toronto Stem Cell Working Group TSCW. Stem cell tourism and Canadian family physicians. Can Fam Physician. 2012;58(4):365–8, e182–5. http://www.ncbi.nlm.nih.gov/pubmed/22611603. Accessed 7 Oct 2019

    PubMed  Google Scholar 

  24. FDA | FDA warns about stem cell therapies. https://www.fda.gov/consumers/consumer-updates/fda-warns-about-stem-cell-therapies. Accessed 3 Dec 2019.

  25. Boggild AK, Sano M, Humar A, Gilman M, Salit I, Kain KC. Travel patterns and risk behavior in solid organ transplant recipients. J Travel Med. 2004;11:37–43.

    Article  Google Scholar 

  26. Hochberg NS, Barnett ED, Chen LH, et al. International travel by persons with medical. Mayo Clin Proc. 2013;88(11):1231–40. https://doi.org/10.1016/j.mayocp.2013.07.018.

    Article  PubMed  Google Scholar 

  27. Roukens AHE, van Dissel JT, de Fijter JW, Visser LG. Health preparations and travel-related morbidity of kidney transplant recipients traveling to developing countries. Clin Transpl. 2007;21(4):567–70. https://doi.org/10.1111/j.1399-0012.2007.00691.x.

    Article  CAS  Google Scholar 

  28. Mikati T, Griffin K, Lane D, Matasar M, Shah MK. International travel patterns and travel risks for stem cell transplant recipients. J Travel Med. 2015;22(1):39–47. https://doi.org/10.1111/jtm.12166.

    Article  PubMed  Google Scholar 

  29. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective recommendations. Biol Blood Marrow Transplant. 2009;15(10):1143–238. https://doi.org/10.1016/j.bbmt.2009.06.019.Guidelines.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. WHO | Fact Sheet: Influenza (Seasonal). https://www.who.int/en/news-room/fact-sheets/detail/influenza-(seasonal). Accessed 7 Apr 2019.

  31. Ison MG. Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses. 2013;7:60–6. https://doi.org/10.1111/irv.12170.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P. European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis. 2013;15(3):219–32. https://doi.org/10.1111/tid.12054.

    Article  CAS  PubMed  Google Scholar 

  33. Goeijenbier M, van Genderen P, Ward BJ, Wilder-Smith A, Steffen R, Osterhaus ADME. Travellers and influenza: risks and prevention. J Travel Med. 2017;24(1) https://doi.org/10.1093/jtm/taw078.

  34. Boggild AK, Castelli F, Gautret P, et al. Latitudinal patterns of travel among returned travelers with influenza: results from the GeoSentinel Surveillance Network, 1997–2007. J Travel Med. 2012;19(1):4–8. https://doi.org/10.1111/j.1708-8305.2011.00579.x.

    Article  PubMed  Google Scholar 

  35. Hirve S, Newman LP, Paget J, et al. Influenza seasonality in the tropics and subtropics – when to vaccinate? PLoS One. 2016;11(4):e0153003. https://doi.org/10.1371/journal.pone.0153003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. WHO | International travel and health: Seasonal influenza. http://www.who.int/ith/vaccines/seasonal_influenza/en/. Accessed 30 July 2018.

  37. WHO | Fact Sheets: Measles. WHO. http://www.who.int/en/news-room/fact-sheets/detail/measles. Accessed 25 Mar 2019.

  38. Measles in Europe: record number of both sick and immunized. February 2019. http://www.euro.who.int/en/media-centre/sections/press-releases/2019/measles-in-europe-record-number-of-both-sick-and-immunized. Accessed 25 Mar 2019.

  39. Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis. 2001;33(s1):S15–21. https://doi.org/10.1086/320899.

    Article  PubMed  Google Scholar 

  40. Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin N Am. 2001;15(1):273–305. https://doi.org/10.1016/S0891-5520(05)70279-8.

    Article  CAS  Google Scholar 

  41. Duchini A, Goss JA, Karpen S, Pockros PJ. Vaccinations for adult solid-organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev. 2003;16(3):357–64. https://doi.org/10.1128/CMR.16.3.357-364.2003.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Chong PP, Avery RK. A comprehensive review of immunization practices in solid organ transplant and hematopoietic stem cell transplant recipients. Clin Ther. 2017;39(8):1581–98. https://doi.org/10.1016/j.clinthera.2017.07.005.

    Article  CAS  PubMed  Google Scholar 

  43. Kotton CN, Kroger AT, Feedman D. Immunocompromised travelers – Chapter 8 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/advising-travelers-with-specific-needs/immunocompromised-travelers. Published 2017. Accessed 30 July 2018.

  44. Danziger-Isakov L, Kumar D, the AST Infectious Diseases Community of Practice. Vaccination in solid organ transplantation. Am J Transplant. 2013;13(s4):311–7. https://doi.org/10.1111/ajt.12122.

    Article  CAS  PubMed  Google Scholar 

  45. Ljungman P, Cordonnier C, Einsele H, et al. Vaccination of hematopoietic cell transplant recipients. Bone Marrow Transplant. 2009;44(8):521–6. https://doi.org/10.1038/bmt.2009.263.

    Article  CAS  PubMed  Google Scholar 

  46. Carpenter PA, Englund JA. How I vaccinate blood and marrow transplant recipients. Blood. 2016;127(23):2824–32. https://doi.org/10.1182/blood-2015-12-550475.

    Article  CAS  PubMed  Google Scholar 

  47. L’Huillier AG, Kumar D. Immunizations in solid organ and hematopoeitic stem cell transplant patients: a comprehensive review. Hum Vaccin Immunother. 2015;11(12):2852–63. https://doi.org/10.1080/21645515.2015.1078043.

    Article  PubMed  PubMed Central  Google Scholar 

  48. WHO | Fact Sheet: Middle East respiratory syndrome coronavirus (MERS-CoV). https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov). Accessed 30 Mar 2019.

  49. Watson JT, Gerber SI. Middle East Respiratory Syndrome (MERS) – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/middle-east-respiratory-syndrome-mers. Accessed 30 Mar 2019.

  50. AlGhamdi M, Mushtaq F, Awn N, Shalhoub S. MERS CoV infection in two renal transplant recipients: case report. Am J Transplant. 2015;15(4):1101–4. https://doi.org/10.1111/ajt.13085.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Motabi IH, Zaidi SZA, Ibrahim MH, et al. Report of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in four patients with hematological malignancies treated at King Fahad Medical City, Riyadh, Saudi Arabia. Blood. 2016;128(22):4903. http://www.bloodjournal.org/content/128/22/4903. Accessed 21 Sept 2019

    Article  Google Scholar 

  52. Hall AJ, Lopman B. Norovirus – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/norovirus. Accessed 8 Apr 2019.

  53. Rosen J. Travel medicine and the solid organ transplant recipient. Infect Dis Clin NA. 2013;27(2):429–57. https://doi.org/10.1016/j.idc.2013.02.009.

    Article  Google Scholar 

  54. Bok K, Green KY. Norovirus gastroenteritis in immunocompromised patients. N Engl J Med. 2013;368(10) https://doi.org/10.1056/NEJMc1301022.

  55. WHO | Fact Sheet: Hepatitis A. https://www.who.int/news-room/fact-sheets/detail/hepatitis-a. Accessed 25 Mar 2019.

  56. Ryan ET, Kain KC. Health advice and immunizations for travelers. N Engl J Med. 2000;342(23):1716–25. https://doi.org/10.1056/NEJM200006083422306.

    Article  CAS  PubMed  Google Scholar 

  57. Nelson NP. Hepatitis A – Chapter 3 – 2018 Yellow Book | Traveler’s Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/hepatitis-a. Published 2017. Accessed 21 Sept 2018.

  58. Jeon HJ, Ro H, Jeong JC, et al. Efficacy and safety of hepatitis A vaccination in kidney transplant recipients. Transpl Infect Dis. 2014;16(3):511–5. https://doi.org/10.1111/tid.12217.

    Article  CAS  PubMed  Google Scholar 

  59. Nelson NP. Updated dosing instructions for immune globulin (human) GamaSTAN S/D for hepatitis A virus prophylaxis. MMWR Morb Mortal Wkly Rep. 2017;66(36):959–60. https://doi.org/10.15585/mmwr.mm6636a5.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Te H, Doucette K. Viral hepatitis: guidelines by the American Society of Transplantation Infectious Disease Community of Practice. Clin Transpl. 2019;33(9):e13514. https://doi.org/10.1111/ctr.13514.

    Article  Google Scholar 

  61. WHO | Fact Sheet: Hepatitis B. https://www.who.int/news-room/fact-sheets/detail/hepatitis-b. Accessed 25 Mar 2019.

  62. Canadian Immunization Guide: Part 3: Vaccination of specific populations. Immunization of immunocompromised persons. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations/page-8-immunization-immunocompromised-persons.html. Published 2017. Accessed 31 May 2017.

  63. WHO | Fact sheet: Hepatitis E. https://www.who.int/news-room/fact-sheets/detail/hepatitis-e. Accessed 25 March 2019.

  64. Hepatitis E – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/hepatitis-e. Accessed 25 Mar 2019.

  65. WHO | Fact Sheet: Poliomyelitis. https://www.who.int/news-room/fact-sheets/detail/poliomyelitis. Accessed 25 Mar 2019.

  66. Global Polio Eradication Initiative – Endemic Countries. http://polioeradication.org/where-we-work/polio-endemic-countries/. Accessed 30 July 2018.

  67. Brandão LGP, Santoro-Lopes G, Oliveira S de S, da Silva EE, do Brasil PEAA. Seroprevalence of antibodies against the three serotypes of poliovirus and IPV vaccine response in adult solid organ transplant candidates. Vaccine. 2018;36(31):4681–6. https://doi.org/10.1016/J.VACCINE.2018.06.031.

    Article  PubMed  Google Scholar 

  68. Brandão LGP, do Brasil PEAA, Oliveira S de S, da SEE, Lopes GS. Seronegativity to polio viruses among previously immunized adult candidates to solid organ transplantation. Braz J Infect Dis. 2018;22(2):150–2. https://doi.org/10.1016/J.BJID.2018.02.003.

    Article  PubMed  Google Scholar 

  69. CDC | Global Health – Newsroom – Yellow Fever. https://www.cdc.gov/globalhealth/newsroom/topics/yellowfever/index.html. Published 2018. Accessed 30 July 2018.

  70. WHO | Fact Sheet – Yellow Fever. http://www.who.int/news-room/fact-sheets/detail/yellow-fever. Accessed 30 July 2018.

  71. Fishman JA. Smallpox and live-virus vaccination in transplant recipients. Am J Transplant. 2003;3(7):786–93. https://doi.org/10.1034/j.1600-6143.2003.00145.x.

    Article  PubMed  Google Scholar 

  72. Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant. 2005;5(1):8–14. https://doi.org/10.1111/j.1600-6143.2004.00708.x.

    Article  PubMed  Google Scholar 

  73. Staples J, Gershman M, Fischer M. Yellow fever vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2010;59 No. RR-7:1–27. www.cdc.gov/mmwr. Accessed 30 July 2018.

  74. Wyplosz B, Burdet C, Fran H. Persistence of yellow fever vaccine – induced antibodies after solid organ transplantation. Am J Transplant. 2013;13:2458–61. https://doi.org/10.1111/ajt.12338.

    Article  CAS  PubMed  Google Scholar 

  75. Gershman M, Staples J. Yellow Fever – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/yellow-fever. Published 2018. Accessed 30 July 2018.

  76. Sicre de Fontbrune F, Arnaud C, Cheminant M, et al. Immunogenicity and safety of yellow fever vaccine in allogeneic hematopoietic stem cell transplant recipients after withdrawal of immunosuppressive therapy. J Infect Dis. 2018;217(3):494–7. https://doi.org/10.1093/infdis/jix564.

    Article  CAS  PubMed  Google Scholar 

  77. Canadian Immunization Guide: Part 4: Active vaccines: Japanese encephalitis vaccine. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-11-japanese-encephalitis-vaccine.html. Accessed 2 Aug 2018.

  78. Hills, S.L; Rabe, I.BF; Fischer M. Japanese encephalitis – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/japanese-encephalitis. Published 2018. Accessed 30 July 2018.

  79. Fischer M, Lindsey N, Staples JE, Hills S, Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep. 2010;59(RR-1):1–27. http://www.ncbi.nlm.nih.gov/pubmed/20224546. Accessed 30 July 2018

    Google Scholar 

  80. Trubiano JA, Johnson D, Sohail A, Torresi J. Travel vaccination recommendations and endemic infection risks in solid organ transplantation recipients. J Travel Med. 2016;23(6):1–15. https://doi.org/10.1093/jtm/taw058.

    Article  Google Scholar 

  81. Darrigo LG, de Sant’Anna Carvalho AM, Machado CM. Chikungunya, Dengue, and Zika in immunocompromised hosts. Curr Infect Dis Rep. 2018;20(4):5. https://doi.org/10.1007/s11908-018-0612-2.

    Article  PubMed  PubMed Central  Google Scholar 

  82. Clemente WT, Pierrotti LC, Abdala E, et al. Recommendations for management of endemic diseases and travel medicine in solid-organ transplant recipients and donors. Transplantation. 2018;102(2):193–208. https://doi.org/10.1097/TP.0000000000002027.

    Article  PubMed  Google Scholar 

  83. Mourão PHO, Gavalda J, Salvador F, Molina I. Recommendations for management of endemic diseases and travel medicine in solid-organ transplant recipients and donors. Transplantation. 2018;102(2S Suppl 2):S81. https://doi.org/10.1097/TP.0000000000002031.

    Article  PubMed  Google Scholar 

  84. Morris MI, Grossi P, Nogueira ML, Azevedo LS. Arboviruses recommendations for solid-organ transplant recipients and donors. Transplantation. 2018;102:S42–51. https://doi.org/10.1097/TP.0000000000002011.

    Article  PubMed  Google Scholar 

  85. Fernandes PFCBC, Siqueira RA, Girão ES, et al. Dengue in renal transplant recipients: clinical course and impact on renal function. World J Transplant. 2017;7(1):57. https://doi.org/10.5500/wjt.v7.i1.57.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Costa SD, da Silva GB, Jacinto CN, et al. Dengue fever among renal transplant recipients: a series of 10 cases in a tropical country. Am J Trop Med Hyg. 2015;93(2):394–6. https://doi.org/10.4269/ajtmh.15-0038.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Prasad N, Bhadauria D, Sharma RK, Gupta A, Kaul A, Srivastava A. Dengue virus infection in renal allograft recipients: a case series during 2010 outbreak. Transpl Infect Dis. 2012;14(2):163–8. https://doi.org/10.1111/j.1399-3062.2011.00699.x.

    Article  CAS  PubMed  Google Scholar 

  88. Nasim A, Anis S, Baqi S, Akhtar SF, Baig-Ansari N. Clinical presentation and outcome of dengue viral infection in live-related renal transplant recipients in Karachi. Pakistan Transpl Infect Dis. 2013;15:516–25. https://doi.org/10.1111/tid.12114.

    Article  CAS  PubMed  Google Scholar 

  89. de Souza Pereira BB, Darrigo Junior LG, de Mello Costa TC, et al. Prolonged viremia in dengue virus infection in hematopoietic stem cell transplant recipients and patients with hematological malignancies. Transpl Infect Dis. 2017;19(4):e12721. https://doi.org/10.1111/tid.12721.

    Article  Google Scholar 

  90. Machado CM, Pereira BB de S, Felix AC, et al. Zika and chikungunya virus infections in hematopoietic stem cell transplant recipients and oncohematological patients. Blood Adv. 2017;1(10):624–7. https://doi.org/10.1182/bloodadvances.2016003285.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Girão ES, Santos BGR, Amaral ES, et al. Chikungunya infection in solid organ transplant recipients. Transplant Proc. 2017;49(9):2076–81. https://doi.org/10.1016/j.transproceed.2017.07.004.

    Article  PubMed  Google Scholar 

  92. Zika Virus | CDC. https://www.cdc.gov/zika/index.html. Accessed 13 Sept 2018.

  93. Polen KD, Gilboa SM, Hills S, et al. Update: interim guidance for preconception counseling and prevention of sexual transmission of Zika virus for men with possible Zika virus exposure – United States, August 2018. MMWR Morb Mortal Wkly Rep. 2018;67(31):868–71. https://doi.org/10.15585/mmwr.mm6731e2.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Nogueira ML, Estofolete CF. Zika virus infection and solid organ transplantation: a new challenge. Am J Transpl. 2017;17(3):791–5. https://doi.org/10.1111/ajt.14047.

    Article  CAS  Google Scholar 

  95. Kotton CN. Zika virus and solid organ transplantation. Transplantation. 2016;100(5):970–2. https://doi.org/10.1097/TP.0000000000001179.

    Article  PubMed  Google Scholar 

  96. Wallace MW, Peterson BW, Shlim DR. Rabies – Chapter 3 – 2018 Yellow Book | travelers’ health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/rabies. Accessed 25 Mar 2019.

  97. WHO | Rabies vaccines: WHO position paper – April 2018. WHO. 2018;16(93):201–220. http://www.who.int/rabies/resources/who_wer9316/en/. Accessed 30 July 2018.

  98. Gibbons RV, Rupprecht CE. Postexposure rabies prophylaxis in immunosuppressed patients. JAMA. 2001;285(12):1574–5. http://www.ncbi.nlm.nih.gov/pubmed/11268256. Accessed 30 July 2018

    Article  CAS  Google Scholar 

  99. WHO | Typhoid. WHO. 2018. https://www.who.int/mediacentre/factsheets/typhoid/en/. Accessed 26 Mar 2019.

  100. Kotton CN. Travel and transplantation. Curr Opin Organ Transplant. 2012; p 1. https://doi.org/10.1097/MOT.0b013e328359266b.

  101. Judd MC, Mintz ED. Typhoid & Paratyphoid fever – chapter 3 – 2018 yellow book | travelers’ health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/typhoid-paratyphoid-fever. Accessed 26 Mar 2019.

  102. Wong KK, Burdette E, Mintz ED. Cholera – chapter 3 – 2018 yellow book | travelers’ health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/cholera. Accessed 27 Mar 2019.

  103. Canadian Immunization Guide: Part 4: Active Vaccines: Cholera and Enterotoxigenic Escherichia Coli (ETEC) Travellers’ Diarrhea Vaccine. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-4-active-vaccines/page-3-cholera-enterotoxigenic-escherichia-coli-travellers-diarrhea-vaccine.html. Published 2017. Accessed 30 July 2018.

  104. Ahmed T, Bhuiyan TR, Zaman K, Sinclair D, Qadri F. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database Syst Rev. 2013;7:CD009029. https://doi.org/10.1002/14651858.CD009029.pub2.

    Article  Google Scholar 

  105. Hill DR, Ericsson CD, Pearson RD, et al. The practice of travel medicine: guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2006;43(12):1499–539. https://doi.org/10.1086/508782.

    Article  CAS  PubMed  Google Scholar 

  106. Committee to Advise on Tropical Medicine and Travel (CATMAT). An Advisory Committee Statement (ACS): Statement on Travellers’ Diarrhea. Public Health Agency of Canada. https://www.canada.ca/en/public-health/services/travel-health/about-catmat/statement-travellers-diarrhea.html. Published 2015. Accessed 9 Aug 2018.

  107. Global Task Force on Cholera Control (GTFCC). WHO | the use of oral cholera vaccines for international workers and travelers to and from cholera-affected countries; 2016. http://www.who.int/cholera/vaccines/OCV_use_International_Workers_Travelers_Technical_Note.pdf. Accessed 9 Aug 2018.

  108. Connor BA. Travelers’ Diarrhea – Chapter 2 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/travelers-diarrhea. Accessed 27 Mar 2019.

  109. O’Reilly CE, Iwamoto M, Griffin PM. Escherichia coli, diarrheagenic – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/escherichia-coli-diarrheagenic#5166. Accessed 27 Mar 2019.

  110. MacNeil JR, Meyer SA. CDC | Meningococcal Disease – Chapter 3 – 2018 Yellow Book | Travelers’ Health. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/meningococcal-disease. Published 2017. Accessed 1 Aug 2018.

  111. Lessa FC. Pneumococcal Disease – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/pneumococcal-disease. Accessed 27 Mar 2019.

  112. Tiwari TS. Tetanus – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/tetanus. Accessed 28 Mar 2019.

  113. von Konig C-HW. Use of antibiotics in the prevention and treatment of Pertussis. Pediatr Infect Dis J. 2005;24(Supplement):S66–8. https://doi.org/10.1097/01.inf.0000160916.47479.22.

    Article  Google Scholar 

  114. CDC | Combined Recommended Immunization Schedule for Adults Aged 19 Years or Older, United States. 2018. https://doi.org/10.7326/M17-3439.

  115. TUBERCULOSIS Global Tuberculosis Report 2018; 2018. www.who.int/tb. Accessed 28 Mar 2019.

  116. Subramanian AK, Theodoropoulos NM. Mycobacterium tuberculosis infections in solid organ transplantation: guidelines from the infectious diseases community of practice of the American Society of Transplantation. Clin Transpl. 2019;33(9):e13513. https://doi.org/10.1111/ctr.13513.

    Article  Google Scholar 

  117. Lobue P. Tuberculosis – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/tuberculosis. Published 2017. Accessed 9 Oct 2018.

  118. Shoham S, Dominguez EA. Emerging fungal infections in solid organ transplant recipients: guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019;33(9):e13525. https://doi.org/10.1111/ctr.13525.

    Article  Google Scholar 

  119. Miller R, Assi M. Endemic fungal infections in solid organ transplantation. Am J Transplant. 2013;13(s4):250–61. https://doi.org/10.1111/ajt.12117.

    Article  CAS  PubMed  Google Scholar 

  120. Panackal AA, Hajjeh RA, Cetron MS, Warnock DW, Cetron MS, Warnock DW. Fungal infections among returning travelers. Clin Infect Dis. 2002;35(9):1088–95. https://doi.org/10.1086/344061.

    Article  PubMed  Google Scholar 

  121. Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH. Fungal infections in immunocompromised travelers. Clin Infect Dis. 2013;56(6):861–9. https://doi.org/10.1093/cid/cis935.

    Article  CAS  PubMed  Google Scholar 

  122. Rappo U, Beitler JR, Faulhaber JR, et al. Expanding the horizons of histoplasmosis: disseminated histoplasmosis in a renal transplant patient after a trip to Bangladesh. Transpl Infect Dis. 2010;12(2):155–60. https://doi.org/10.1111/j.1399-3062.2009.00466.x.

    Article  CAS  PubMed  Google Scholar 

  123. Hart J, Dyer JR, Clark BM, McLellan DG, Perera S, Ferrari P. Travel-related disseminated Penicillium marneffei infection in a renal transplant patient. Transpl Infect Dis. 2012;14(4):434–9. https://doi.org/10.1111/j.1399-3062.2011.00700.x.

    Article  CAS  PubMed  Google Scholar 

  124. Types of Fungal Diseases | Fungal Diseases | CDC. https://www.cdc.gov/fungal/diseases/index.html. Accessed 5 Apr 2019.

  125. Boggild AK, Yohanna S, Keystone JS, Kain KC. Prospective analysis of parasitic infections in Canadian travelers and immigrants. J Travel Med. 2006;13(3):138–44. https://doi.org/10.1111/j.1708-8305.2006.00032.x.

    Article  PubMed  Google Scholar 

  126. Schwartz BS, Mawhorter SD. Parasitic infections in solid organ transplantation. Am J Transplant. 2013;13(s4):280–303. https://doi.org/10.1111/ajt.12120.

    Article  CAS  PubMed  Google Scholar 

  127. La Hoz RM, Morris MI. Tissue and blood protozoa including toxoplasmosis, Chagas disease, Leishmaniasis, Babesia, Acanthamoeba, Balamuthia, and Naegleria in solid organ transplant recipients – guidelines from the Infectious Diseases Community of Practice of the American Society of Transplantation. Clin Transpl. 2019;33(9):e13546. https://doi.org/10.1111/ctr.13546.

    Article  Google Scholar 

  128. WHO | Fact Sheet: Malaria. https://www.who.int/news-room/fact-sheets/detail/malaria. Accessed 28 Mar 2019.

  129. Pierrotti LC, Levi ME, Di Santi SM, Segurado AC, Petersen E. Malaria disease recommendations for solid organ transplant recipients and donors. Transplantation. 2018;102:S16–26. https://doi.org/10.1097/TP.0000000000002017.

    Article  PubMed  Google Scholar 

  130. Arguin PM, Tan KR. CDC | malaria – chapter 3 – 2018 yellow book | travelers’ health. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/malaria. Published 2017. Accessed 30 July 2018.

  131. WHO | Fact Sheet: Leishmaniasis. https://www.who.int/news-room/fact-sheets/detail/leishmaniasis. Accessed 30 Mar 2019.

  132. Clemente WT, Mourão PHO, Lopez-Medrano F, Schwartz BS, García-Donoso C, Torre-Cisneros J. Visceral and cutaneous leishmaniasis recommendations for solid organ transplant recipients and donors. Transplantation. 2018;102(2S Suppl 2):S8–S15. https://doi.org/10.1097/TP.0000000000002018.

    Article  PubMed  Google Scholar 

  133. Herwaldt BL, Magill AJ. Leishmaniasis, visceral – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/leishmaniasis-visceral. Accessed 30 Mar 2019.

  134. WHO | Fact Sheet: Trypanosomiasis, human African (sleeping sickness). https://www.who.int/news-room/fact-sheets/detail/trypanosomiasis-human-african-(sleeping-sickness). Accessed 30 Mar 2019.

  135. WHO | Fact Sheet: Chagas disease (American trypanosomiasis). https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis). Accessed 30 Mar 2019.

  136. Pierrotti LC, Carvalho NB, Amorin JP, Pascual J, Kotton CN, López-Vélez R. Chagas disease recommendations for solid-organ transplant recipients and donors. Transplantation. 2018;102:S1–7. https://doi.org/10.1097/TP.0000000000002019.

    Article  PubMed  Google Scholar 

  137. Montgomery S. Trypanosomiasis, American (Chagas Disease) – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/trypanosomiasis-american-chagas-disease. Accessed 30 Mar 2019.

  138. Kotton CN, Lattes R. Parasitic infections in solid organ transplant recipients. Am J Transplant. 2009;9(SUPPL. 4) https://doi.org/10.1111/j.1600-6143.2009.02915.x.

  139. Jarque I, Salavert M, Pemán J. Parasitic infections in hematopoietic stem cell transplantation. Mediterr J Hematol Infect Dis. 2016;8(1):e2016035. https://doi.org/10.4084/MJHID.2016.035.

    Article  PubMed  PubMed Central  Google Scholar 

  140. Lubin AS, Snydman DR, Miller KB. Persistent babesiosis in a stem cell transplant recipient. Leuk Res. 2011;35(6):e77–8. https://doi.org/10.1016/j.leukres.2010.11.029.

    Article  PubMed  Google Scholar 

  141. Abanyie F. Strongyloidiasis – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/strongyloidiasis. Accessed 30 Mar 2019.

  142. Camargo LFA, Kamar N, Gotuzzo E, Wright AJ. Schistosomiasis and Strongyloidiasis recommendations for solid-organ transplant recipients and donors. Transplantation. 2018;102:S27–34. https://doi.org/10.1097/TP.0000000000002016.

    Article  PubMed  Google Scholar 

  143. Montgomery S. Schistosomiasis – Chapter 3 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/infectious-diseases-related-to-travel/schistosomiasis. Accessed 30 Mar 2019.

  144. Table of Contents | 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/table-of-contents. Accessed 30 Mar 2019.

  145. Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007;357:2601–14. https://doi.org/10.1016/j.semnephrol.2007.03.006.

    Article  CAS  PubMed  Google Scholar 

  146. Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15(10):1143–238. https://doi.org/10.1016/j.bbmt.2009.06.019.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  147. Winter K. Travel Health Kits – Chapter 2 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/travel-health-kits. Published 2017. Accessed 31 Aug 2018.

  148. Avery RK, Michaels M. Update on immunizations in solid organ transplant recipients: what clinicians need to know. Am J Transplant. 2008;8(1):9–14. https://doi.org/10.1111/j.1600-6143.2007.02051.x.

    Article  CAS  PubMed  Google Scholar 

  149. Canadian Immunization Guide: Part 3: Vaccination of Specific Populations. https://www.canada.ca/en/public-health/services/publications/healthy-living/canadian-immunization-guide-part-3-vaccination-specific-populations.html. Accessed 7 Jan 2018.

  150. Aung AK, Trubiano JA, Spelman DW. Travel risk assessment, advice and vaccinations in immunocompromised travellers (HIV, solid organ transplant and haematopoeitic stem cell transplant recipients ): a review. Travel Med Infect Dis. 2015;13:31–47. https://doi.org/10.1016/j.tmaid.2014.12.007.

    Article  CAS  PubMed  Google Scholar 

  151. Committee to Advise on Tropical Medicine and Travel (CATMAT). An Advisory Committee Statement (ACS): the immunocompromised traveller. Canada Commun Dis Rep. 2007;33(ACS-4):1–24. https://www.canada.ca/content/dam/phac-aspc/migration/phac-aspc/publicat/ccdr-rmtc/07pdf/acs33-04.pdf. Accessed 30 July 2018

    Google Scholar 

  152. Rubin LG, Levin MJ, Ljungman P, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):e44–e100. https://doi.org/10.1093/cid/cit684.

    Article  PubMed  Google Scholar 

  153. Griffin PM, Hlavsa MC, Yoder JS. Food and water precautions – Chapter 2 – 2018 Yellow Book | Travelers’ Health | CDC. https://wwwnc.cdc.gov/travel/yellowbook/2018/the-pre-travel-consultation/food-water-precautions. Published 2017. Accessed 1 Aug 2018.

  154. Eat and drink safely – travel health and safety. Government of Canada. https://travel.gc.ca/travelling/health-safety/food-water. Published 2018. Accessed 1 Aug 2018.

  155. Beeching NJ, Carratalà J, Razonable RR, Oriol I, Vilela EG. Traveler’s Diarrhea recommendations for solid organ transplant recipients and donors. Transplantation. 2018;102:S35–41. https://doi.org/10.1097/TP.0000000000002015.

    Article  PubMed  Google Scholar 

  156. Riddle MS, Connor BA, Beeching NJ, et al. Guidelines for the prevention and treatment of travelers ’ diarrhea: a graded expert panel report. J Travel Med. 2018;24(Suppl 1):S63–80. https://doi.org/10.1093/jtm/tax026.

    Article  Google Scholar 

  157. UNWTO Tourism Highlights. https://doi.org/10.18111/9789284419876.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Arianne Buchan .

Editor information

Editors and Affiliations

Section Editor information

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Buchan, C.A. (2021). Transplant Tourism and the Traveling Transplant Recipient: Infection Mitigation and Treatment Strategies. In: Morris, M.I., Kotton, C.N., Wolfe, C.R. (eds) Emerging Transplant Infections. Springer, Cham. https://doi.org/10.1007/978-3-030-25869-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-25869-6_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-25868-9

  • Online ISBN: 978-3-030-25869-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics